Please see below for a list of search results.
The HTA was asked to provide any record of evidence to show that electoral fraud would have been committed in the May local elections this year.
The HTA was asked to provide information on staff pay and executive emoluments by financial year from 2010 to 2018.
The HTA’s high-level aims, objectives and key milestones and deliverables for 2018/19 are set out in this section. This information is supported by our key performance indicators (KPIs) and performance indicators (PIs), which set out how we will measure whether we are achieving those aims.
This business plan sets out our ambitions for 2018/19. The HTA operates a continuous business planning process - we maintain a pipeline of proposed business activities over a three-year period, which allows us to adapt and plan in response to changes in our operating environment.
Our strategy was developed following a fundamental evaluation of the extent to which our current strategic approach protects public and professional confidence in the proper use, and quality and safety, of human tissues, cells and organs.
During 2017, the HTA undertook a fundamental review of its strategy. This exercise gave us considerable reassurance that the public and professionals think we are on the right track with our regulatory approach.